@article{a082b22b5004477a8b6049cfc53b3e3a,
title = "Nonmyeloablative Hematopoietic Cell Transplantation: Status Quo and Future Perspectives",
author = "Marco Mielcarek and Sandmaier, \{Brenda M.\} and Maloney, \{David G.\} and Michael Maris and McSweeney, \{Peter A.\} and Ann Woolfrey and Thomas Chauncey and Lyle Feinstein and Dietger Niederwieser and Blume, \{Karl G.\} and Stephen Forman and Beverly Torok-Storb and Rainer Storb",
note = "In nonmyeloablative allogeneic hematopoietic stem cell transplantation (HSCT), high-dose cytotoxic therapy as the conceptual basis for treating hematopoietic malignancies has been replaced by graft-versus-tumor effects. The use of potent pre- and postgrafting immunosuppression derived from preclinical studies has allowed omission of myeloablative cytotoxic therapy without compromising hematopoietic donor cell engraftment.",
year = "2002",
month = mar,
day = "1",
doi = "10.1023/A:1014532401666",
language = "American English",
volume = "22",
journal = "Journal of Clinical Immunology",
}